Tecfidera® approved in the European Union
Posted: Mon Feb 03, 2014 7:45 am
Tecfidera® (dimethyl fumarate) has been approved by the European Commission (EC) as a first-line oral treatment for people with relapsing-remitting multiple sclerosis (RRMS), the most common form of multiple sclerosis (MS). Biogen Idec will begin to introduce Tecfidera in initial European Union (EU) countries in the coming weeks..... Read More - http://www.ms-uk.org/BG12